Internal Medicine Multi-Spec is categorized under Gastroenterologists in Bridgeport, CT and active since 1974.
Internal Medicine Multi-Spec was established in 1974, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Gastroenterologists business, which does work in the B2C market, and is classified as a Gastroenterologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Yousuf Ali at the company’s single location by writing to 515 North Ridgefield Avenue, Bridgeport, Connecticut CT 06610 or by phoning (203) 334-7654. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Internal Medicine Multi-Spec |
| Contact Person: | Yousuf Ali |
| Address: | 515 North Ridgefield Avenue, Bridgeport, Connecticut 06610 |
| Phone Number: | (203) 334-7654 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1974 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Gastroenterologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Internal Medicine Multi-Spec was started in 1974 to provide professional Gastroenterologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Yousuf Ali for inquiries that concern Internal Medicine Multi-Spec by calling the company number (203) 334-7654, as your correspondence is most welcome. Additionally, the physical location of the single location of Internal Medicine Multi-Spec can be found at the coordinates 41.19376,-73.16392 as well as the street address 515 North Ridgefield Avenue in Bridgeport, Connecticut 06610.
For its online presence, you may visit Internal Medicine Multi-Spec’s website at and engage with its social media outlets through on Twitter and on Facebook.